funder-graph

FundersCTAlliance for Cancer Gene Therapy Inc › 2022

Grants paid by Alliance for Cancer Gene Therapy Inc, tax year 2022

EIN 06-1619523 · Stamford, CT · Form 990, Schedule I · NTEE T30

In tax year 2022, Alliance for Cancer Gene Therapy Inc (EIN 06-1619523) reported 6 grants paid totaling $1,237,350. Dataset version 2026.09.0, built 2026-09-03.

20212022202320242025

Every grant, 2022

Grants reported by Alliance for Cancer Gene Therapy Inc for tax year 2022
Tax yearRecipientMatchAmountTypePurposeSource filing
2022Pci New York, NYA$750,009paidCANCER RESEARCH202310669349301401
2022Zureikat U Pitts Pittsburgh, PAA$481,942paidCANCER RESEARCH202310669349301401
2022Fraiette Ttee Upenn Philadelphia, PAA$1,957paidCANCER RESEARCH202310669349301401
2022Gottschalk St Jude Memphis, TNA$1,878paidCANCER RESEARCH202310669349301401
2022Chen Yale Univ New Haven, CTA$891paidCANCER RESEARCH202310669349301401
2022Brownicahn School New York, NYA$673paidCANCER RESEARCH202310669349301401

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.